The use of central venous lines carries a significant risk for serious complications and high economic costs. Lately, the peripherally inserted central venous catheter (PICC) has gained in popularity due to presumed advantages over other central venous lines.
The Vygon range of peripherally inserted catheters provides safe and reliable vascular access. They are intended for use in patients who require mid to long-term IV therapy and may be used to administer fluids, antibiotics, chemotherapy, parenteral nutrition, pain management drugs, and for blood sampling. Vygon specializes in vascular access devices made from biostable polyurethane, which offers enhanced mechanical and biochemical stability throughout treatment. Catheters made from polyurethane have the advantage of providing extra stiffness, which aids insertion, and then become soft and pliable at body temperature.
Lifecath PICC is a peripherally inserted central catheter (basilic vein, cephalic vein, median cubital vein...) in biostable polyurethane available as single or double lumen catheter.
Lifecath PICC is intended for use in patients who require mid-long term IV therapy. The benefits to users are that the Lifecath PICC provides them with a line that has an indwell time for the duration of the patient’s therapy, and it is a cost-effective solution. For the patients, it offers a reduction in complications and the number of cannulations as well as a reduction in the trauma of long-term lines. Lifecath PICC is easy to insert, especially in a nurse-led practice, and it reduces costs and time.
Lifecath Midline is intended for use in patients who require mid-long term IV therapy. Patients identified as needing non-irritant/non-vesicant intermediate to long-term intravenous antibiotic therapy benefit from the early placement of a Midline. The insertion of a Midline facilitates early discharge for continued antibiotic therapy in the community, as well as reducing the number of patient bed days and the risk of the patient acquiring a healthcare-associated infection. A Midline also reduced the number of missed antibiotic doses resulting from unreliable intravenous access, which could result in treatment delays. Midlines inserted using ultrasound and a micro-introducer technique also provide reliable access for patients who are difficult to cannulate, preventing delayed or missed treatment doses and the need for the insertion of an acute central line or femoral line. The benefit to the patient is that a Midline avoids repeated painful cannulation attempts and the placement of a Midline in the upper arm is far more comfortable.